Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Impact of Social Risks on Cancer Screening Among Underserved Communities
Research & Development Impact of Social Risks on Cancer Screening Among Underserved Communities

The relationship between social risks and routine cancer screenings signifies a complex and pressing public health issue, particularly regarding how housing instability or food insecurity among patients significantly hinders essential cancer preventive care. A new study conducted by researchers at

Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes
Research & Development Dual Screening for Liver Fibrosis and Eye Disease in Type 2 Diabetes

In a groundbreaking study from Karolinska Institutet in Sweden, researchers have introduced an innovative method aimed at concurrently screening for liver fibrosis and eye disease in people living with type 2 diabetes. By combining liver damage screening with the already established retina scanning

Widening Vaccine Inequality in England Poses Public Health Concern
Research & Development Widening Vaccine Inequality in England Poses Public Health Concern

Recent data from a comprehensive study published in The BMJ have revealed alarming and persistent inequalities in childhood vaccination rates across England, underscoring a major public health concern. The study meticulously analyzed general practice data from 2019 to 2023, revealing that

Is Ticagrelor's Approval Based on Questionable PLATO Trial Data?
Research & Development Is Ticagrelor's Approval Based on Questionable PLATO Trial Data?

The approval of ticagrelor, an anti-platelet drug marketed as Brilinta in the US and Brilique in Europe, has been mired in controversy since the publication of the PLATO trial. This landmark clinical trial, which led to the drug's worldwide approval, has faced intense scrutiny over the

High-Dose Chemotherapy and ASCT No Extra Benefit in MCL Remission
Research & Development High-Dose Chemotherapy and ASCT No Extra Benefit in MCL Remission

The findings from the late-breaking research presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition have brought new insights into the treatment of mantle cell lymphoma (MCL). The phase 3 study EA4151, conducted by the ECOG-ACRIN Cancer Research Group, investigated

Comprehensive TPMT Genotyping Urged To Predict Thiopurine Drug Response
Research & Development Comprehensive TPMT Genotyping Urged To Predict Thiopurine Drug Response

Mayo Clinic researchers have made a case for comprehensive TPMT genotyping across various ancestries to better predict drug response and minimize adverse reactions. Their recent discovery of the TPMT∗8 allele, a gene variant associated with reduced metabolism of thiopurine drugs, has revolutionary p

How Are Genetic Challenges Impacting H5N1 Avian Flu Detection?
Research & Development How Are Genetic Challenges Impacting H5N1 Avian Flu Detection?

In an intriguing development, a genetic analysis was performed on an H5N1 avian flu infection detected in a child from California in November, leading to significant findings and presenting several challenges. The US Centers for Disease Control and Prevention (CDC) announced that the virus RNA

EPA and FDA's Vital Role in Public Health: Recent Regulatory Actions
Management & Regulatory EPA and FDA's Vital Role in Public Health: Recent Regulatory Actions

Imagine a world where the air we breathe, the water we drink, and the food we eat are all unchecked, teeming with unseen hazards. For many, this is a nightmarish scenario, yet it highlights the importance of regulatory bodies such as the Environmental Protection Agency (EPA) and the Food and Drug

How Does a Bacterial Toxin Accelerate Colorectal Cancer Spread?
Research & Development How Does a Bacterial Toxin Accelerate Colorectal Cancer Spread?

In a groundbreaking study conducted by researchers at UF Health Cancer Center and their international partners, scientists have found compelling evidence that a toxin produced by a common foodborne bacterium, Campylobacter jejuni (C. jejuni), significantly accelerates the spread of colorectal

How Will the New HWE Reaction Advance Anti-Cancer Drug Development?
Research & Development How Will the New HWE Reaction Advance Anti-Cancer Drug Development?

The field of organic chemistry has witnessed a significant breakthrough with the development of a highly (E)-selective Weinreb amide-type Horner–Wadsworth–Emmons (HWE) reaction. This advancement was achieved by a team from the Department of Applied Chemistry at Tokyo University of Science (TUS) in J

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later